Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2004-12-24
2008-11-25
Solola, Taofiq A (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C562S407000
Reexamination Certificate
active
07456218
ABSTRACT:
The present invention provides a novel compound represented by the formula (I) wherein each symbol is as defined in the specification, a salt thereof and a prodrug thereof having a superior GPR40 receptor function modulating action, which can be used as an insulin secretagogue, an agent for the prophylaxis or treatment of diabetes and the like. They unexpectedly show superior GPR40 receptor agonist activity, and also show superior properties as a pharmaceutical product, such as stability and the like. Thus, they can be safe and useful pharmaceutical agents for the prophylaxis or treatment of GPR40 receptor related diseases in mammals.
REFERENCES:
patent: 2003-261491 (2003-09-01), None
patent: 97/31907 (1997-09-01), None
patent: 99/11255 (1999-03-01), None
patent: 00/64876 (2000-11-01), None
patent: 01/00603 (2001-01-01), None
patent: 01/55085 (2001-08-01), None
patent: 01/79150 (2001-10-01), None
patent: 02/053547 (2002-07-01), None
patent: 02/083616 (2002-10-01), None
patent: 02/092590 (2002-11-01), None
patent: 02/100813 (2002-12-01), None
patent: 03/018553 (2003-03-01), None
patent: 03/084916 (2003-10-01), None
patent: 03/099793 (2003-12-01), None
patent: 2004/000315 (2003-12-01), None
patent: 2004/041266 (2004-05-01), None
patent: 2004/091604 (2004-10-01), None
Y. Itoh et al., “Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40”, Nature, vol. 422, No. 6928, pp. 173-176, Mar. 13, 2003.
Kitamura Shuji
Negoro Nobuyuki
Yasuma Tsuneo
Solola Taofiq A
Takeda Pharmaceutical Company Limited
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
3-(4-benzyloxyphenyl) propanoic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-(4-benzyloxyphenyl) propanoic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-(4-benzyloxyphenyl) propanoic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4036478